When the expression of the RALGAPs was analyzed in the METABRIC and TCGA BC cohorts, we found that RALGAPA1, RALGAPA2, and RALGAPB were all expressed at significantly greater levels in HER2+ BC relative to the TNBC patients (Supplementary Figure S10). This evidence concerns the gene RALGAPB and breast cancer.